Fragile X syndrome and connective tissue dysregulation
- 10 November 2018
- journal article
- review article
- Published by Wiley in Clinical Genetics
- Vol. 95 (2) , 262-267
Abstract
Fragile X syndrome (FXS) is the most common cause of inherited intellectual disabilities and autism spectrum disorders, and it is an X‐linked disorder in which there is a deficiency of the fragile X mental retardation 1 protein. This protein is crucial in regulating translation of mRNAs related to dendritic maturation and cognitive development. The phenotype of FXS is characterized by neurobehavioral alterations, social deficits, communication difficulties, and findings which suggest an alteration of connective tissue, especially in the ligaments and muscles, cardiovascular system and genitourinary system. Connective tissue connects and supports all other tissues of the body and is composed of cells and extracellular matrix (ECM). Several proteins have been involved in the connective tissue abnormalities associated with the FXS, such as matrix metalloproteinase 9, which plays an important role in the homeostasis of the ECM, being a potential therapeutic target for certain tetracycline antibiotics that have shown beneficial effects in FXS. Here, we review connective tissue problems described in FXS.Keywords
This publication has 63 references indexed in Scilit:
- FMRP targets distinct mRNA sequence elements to regulate protein expressionNature, 2012
- FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and AutismCell, 2011
- Potential therapeutic interventions for fragile X syndromeTrends in Molecular Medicine, 2010
- Fragile X: A Family of DisordersAdvances in Pediatrics, 2009
- Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinatelyProceedings of the National Academy of Sciences, 2008
- The microRNA pathway and fragile X mental retardation proteinBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2008
- Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascadeProceedings of the National Academy of Sciences, 2006
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradoxCell, 1991
- Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndromeCell, 1991